Exclaro
Exclaro
  • Home
  • Contact Us
  • More
    • Home
    • Contact Us
  • Home
  • Contact Us

Rapid adaptable disease screening solutions

Rapid adaptable disease screening solutionsRapid adaptable disease screening solutionsRapid adaptable disease screening solutionsRapid adaptable disease screening solutions

















Contact Us

Rapid adaptable disease screening solutions

Rapid adaptable disease screening solutionsRapid adaptable disease screening solutionsRapid adaptable disease screening solutionsRapid adaptable disease screening solutions

















Contact Us

Our Mission

Aiming to deliver quick screening tests by offering a user-friendly 

point-of-care solution for getting multiple results rapidly using body fluids

About Us

Exclaro is a dynamic, Montreal-based technology company aiming to revolutionize disease diagnosis by offering a rapid, customized, easy-to-use screening solution that can be deployed anywhere.


Our end goal is a portable diagnostic device capable of detecting diseases rapidly from blood, urine or saliva.

We are experts in rapid testing

Fast

User friendly

Low cost

Results in seconds

Low cost

User friendly

Low cost

Cheaper than current tests

on the market

Non-invasive

User friendly

User friendly

Biofluid-based

User friendly

User friendly

User friendly

No training required

AI-driven

Multi-detection

AI-driven

New detections can be added by software update

Reliable

Multi-detection

AI-driven

Highly sensitive

(meets WHO standards)

Multi-detection

Multi-detection

Multi-detection

Multiple test results are obtained from one sample

Label-free

Multi-detection

Multi-detection

No sample preparation

Executive Team

Alexandre Triquet

François Daoust, MSc Eng

François Daoust, MSc Eng

CEO, Founder

François Daoust, MSc Eng

François Daoust, MSc Eng

François Daoust, MSc Eng

General manager, Co-founder

Éric Dandurand

Éric Dandurand

François Daoust, MSc Eng

Nassim Ksantini, MSc Eng

COO, Co-founder

Nassim Ksantini, MSc Eng

François Daoust, MSc Eng

Nassim Ksantini, MSc Eng

CTO, Co-founder

Richard Marchand, MD

Catherine Frigon, LLB, MBA

Catherine Frigon, LLB, MBA

Chief Medical Officer, Co-founder

Catherine Frigon, LLB, MBA

Catherine Frigon, LLB, MBA

Catherine Frigon, LLB, MBA

CLO

Jean-François Lorrain

Catherine Frigon, LLB, MBA

Jean-François Lorrain

CIO, Merging and acquisitions

Michel Lecavalier

Catherine Frigon, LLB, MBA

Jean-François Lorrain

CFO

Clinical and Science Advisors

Frédéric Leblond, PhD Eng

Kevin Petrecca, MD, PhD, FRCS(C)

Frédéric Leblond, PhD Eng

Principal science advisor, Co-founder

Richard Marchand, MD

Kevin Petrecca, MD, PhD, FRCS(C)

Frédéric Leblond, PhD Eng

CMO, Co-founder

Kevin Petrecca, MD, PhD, FRCS(C)

Kevin Petrecca, MD, PhD, FRCS(C)

Kevin Petrecca, MD, PhD, FRCS(C)

Principal clinical advisor

Eric Marple

Frédérick Dallaire, PhD

Kevin Petrecca, MD, PhD, FRCS(C)

Engineering advisor

Frédérick Dallaire, PhD

Frédérick Dallaire, PhD

Frédérick Dallaire, PhD

AI/data advisor

Board Advisors

Olivier Mattmann, PhD

Olivier Mattmann, PhD

Olivier Mattmann, PhD

CBRN advisor and European business partner

Kevin Gilmore, LLB

Olivier Mattmann, PhD

Olivier Mattmann, PhD

Legal advisor

Étienne Boulay

Olivier Mattmann, PhD

Arnaud Gason-Nadon

Sports division and marketing

Arnaud Gason-Nadon

Arnaud Gason-Nadon

Arnaud Gason-Nadon

Sports industry development

Jonathan Martin

Arnaud Gason-Nadon

Jonathan Martin

USA business partner

Our Partners

Exclaro

400 Rue Montfort, Local M-2140, Montréal, Quebec H3C 4J9, Canada

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Copyright © 2025 Exclaro - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept